Podiatry care and amorolfine: An effective treatment of foot distal onychomycosis

A. Zalacain*, L. Ruiz, G. Ramis, V. Novel, J. M. Ogalla, M. A. Calvo, T. Vinuesa

*Autor corresponent d’aquest treball

    Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

    1 Citació (Scopus)

    Resum

    Background: Onychomycosis constitute more than 40% of onychopathies in humans. Several suggestions have been published to standardize the treatment protocols. Objectives: The aim of this study was to evaluate the risk factors for onychomycosis as well as to compare laboratory and clinical data and to determine the effectiveness of amorolfine in the treatment. Method: Samples were obtained from 360 patients and processed in the laboratory. Treatment and improvement of lesions were followed up for 6 and 9 months in all cases. Results: T. mentagrophytes and T. rubrum the most common dermatophytes whereas among non-dermatophytes the order of incidence was Scopularopsis brevicaulis, Acremonium roseum, Aspergillus spp., and Fusarium sp. Onychomycosis was successfully treated by amorolfine in 75.3% of cases. © 2006 Elsevier Ltd. All rights reserved.
    Idioma originalAnglès
    Pàgines (de-a)149-152
    Nombre de pàgines4
    RevistaFoot
    Volum16
    Número3
    DOIs
    Estat de la publicacióPublicada - 1 de set. 2006

    Fingerprint

    Navegar pels temes de recerca de 'Podiatry care and amorolfine: An effective treatment of foot distal onychomycosis'. Junts formen un fingerprint únic.

    Com citar-ho